Get started
Author

Chutima Kunacheewa

Observed name: Kunacheewa, Chutima
ORCID: 0000-0002-3429-5826
Observed ORCID: 0000-0002-3429-5826
OpenAlex ID: A5081546323
New Drugs in Multiple Myeloma
2019 · Chutima Kunacheewa, Robert Z. Orlowski · Annual Review of Medicine · 42
Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis
2018 · Weerapat Owattanapanich, Kittima Suphadirekkul, et al. · BMC Cancer · 37
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia
2019 · Samer Tabchi, Rajit Nair, et al. · Clinical Lymphoma Myeloma & Leukemia · 26
Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in Thailand
2024 · Sudjit Luanpitpong, Phatchanat Klaihmon, et al. · Molecular Therapy Oncology · 16
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study
2020 · Chutima Kunacheewa, Hans C. Lee, et al. · Clinical Lymphoma Myeloma & Leukemia · 16
Comparative Efficacy and Clinical Outcomes of Haploidentical Stem Cell Transplantation to Other Stem Sources for Treatment in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: A Systematic Review and Meta-Analysis
2020 · Chutima Kunacheewa, Patompong Ungprasert, et al. · Cell Transplantation · 15
High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implications
2020 · Chutima Kunacheewa, Elisabet E. Manasanch · Best Practice & Research Clinical Haematology · 13
The role of soluble B cell maturation antigen as a biomarker in multiple myeloma
2022 · Mohammed Alomari, Chutima Kunacheewa, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
2020 · Chutima Kunacheewa, Weerapat Owattanapanish, et al. · Cell Transplantation · 10
PDF
Matched sibling donor hematopoietic stem cell transplantation for thalassemia
2016 · Surapol Issaragrisil, Chutima Kunacheewa · Current Opinion in Hematology · 9
Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up
2021 · Elisabet E. Manasanch, Chutima Kunacheewa, et al. · Blood Cancer Journal · 5
PDF
Gene expression profiling predicts relapse‐free and overall survival in newly diagnosed myeloma patients treated with novel therapies
2021 · Elisabet E. Manasanch, David Berrios, et al. · British Journal of Haematology · 5
PDF
A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia
2019 · Chutima Kunacheewa, Pakaporn Thongthang, et al. · Hematology · 5
Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand Population
2022 · Chutirat Jirabanditsakul, Sumana Dakeng, et al. · Technology in Cancer Research & Treatment · 4
The Real-Life Efficacy of Fixed-Dose Hypomethylating Agents in Older Patients With Acute Myeloid Leukemia: A 10-Year Experience
2021 · Tarinee Rungjirajittranon, Smith Kungwankiattichai, et al. · Clinical Lymphoma Myeloma & Leukemia · 4
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy
2021 · Chutima Kunacheewa, Lei Feng, et al. · British Journal of Haematology · 4
PDF
Advancing the pathway to allogeneic hematopoietic stem cell transplantation through a physician–nurse coordinator system in patients with acute leukemia
2025 · Chidapa Auepisit, Weerapat Owattanapanich, et al. · Scientific Reports · 3
PDF
High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients’ samples
2023 · Ployploen Phikulsod, Sanya Sukpanichnant, et al. · Pathology & Oncology Research · 3
PDF
Optimizing Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Early Step-Down Ward Versus HEPA-Filtered Rooms: A Practical Approach for Resource-Limited Settings
2025 · Chutima Kunacheewa, Sukanpuk Niwatkittipon, et al. · Transplantation and Cellular Therapy · 2
Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup
2025 · Chandramouli Nagarajan, Natasha Fay Anthony, et al. · The Lancet Regional Health - Western Pacific · 2
PDF
Concurrent myasthenia gravis-related cervical thymoma in a patient with diffuse large B-cell lymphoma: a case report
2022 · Chutima Kunacheewa, Sattawut Wongwiangjunt, et al. · Journal of Medical Case Reports · 2
PDF
Minimal residual disease in multiple myeloma 2019
2019 · Chutima Kunacheewa, Pei Lin, et al. · Advances in Cell and Gene Therapy · 2
OA-36 SBCMA predicts progression and is a biomarker of response in myeloma precursor disease followed on prospective studies
2023 · Wei Tan, Chutima Kunacheewa, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Abstract 775: Integrative genomic and transcriptomic profiling of myeloma precursors in a prospective longitudinal observational study (ORIGIN)
2023 · Minghao Dang, Chutima Kunacheewa, et al. · Cancer Research · 1
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impact
2021 · Chutima Kunacheewa, Elisabet E. Manasanch · Expert Review of Hematology · 1
Works count: 48
Citation count: 241
H-index: 9
I10-index: 9
Year
Topic
Type